Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Use of drugs, medical aids and remedies of prevalent HD patients in 2015 and 2016

From: Epidemiology and health care utilization of patients suffering from Huntington’s disease in Germany: real world evidence based on German claims data

 Women (n = 139)Men (n = 169)All (n = 308)
n%Mean costs per patient and yearMean DDD per yearn%Mean costs per patient and yearMean DDD per yearn%Mean costs per patient and yearMean DDD per year
Drugs
 Anticonvulsants2115.1%153.76 €132.93017.8%146.93 €124.75116.6%149.74 €128.1
 Antidepressants6244.6%129.50 €356.47745.6%121.78 €349.113945.1%125.22 €352.3
 Antipsychotics9165.5%633.34 €467.611568.0%495.95 €322.220666.9%556.64 €386.5
 Hypnotics1510.8%67.54 €86.6158.9%43.22 €84.0309.7%55.38 €85.3
 Opioids2014.4%214.81 €47.62514.8%90.98 €33.74514.6%146.02 €39.9
Medical aids
 Nursinga4028.8%4627.2%8627.9%
 Physical therapy6546.8%795.43 €7846.2%791.01 €14346.4%793.02 €
 Psychotherapy///< 5//103.2%553.39 €
 Speech therapy2820.1%1232.98 €4224.9%966.42 €7022.7%1073.04 €
Remedies
 Walking aid1410.1%128.33 €158.9%61.28 €299.4%93.65 €
 Wheelchair use2719.4%481.91 €2917.2%591.71 €5618.2%538.77 €
  1. Numbers which are too low or might allow indirect calculability of too low case numbers cannot be displayed due to data protection reasons
  2. aCosts for nursing services were not comprised by the database